TBXA2R and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, the data suggest TBXA2R expression is elevated to a greater extent in some cancers (such as CML, meningioma, AML, mesothelioma and renal cancer) where the significance is yet to be determined.